Dr. Shirley's professional experience and practiceAbout Our ServicesFill out our information form for serviceContact Dr. ShirleyHow to know when you need to talk for help..
click here to return to talkingdoc.com home page

 

Medication Information:
Clozapine (generic) ~ Clozaril (brand)

Classification: Atypical antipsychotic
Common Usage: Clozapine is indicated for treatment-resistant psychosis and for suicidal behavior in patients with schizophrenia or schizoaffective disorder who are at chronic risk.

CommonDosages: The usual starting dose of clozapine is one-half of a 25-mg tablet (12.5) mg) given at bedtime and then twice daily, and then dosage increases of 25 to 50 mg daily.  Depending on the side effects, the clozapine dose is typically about 300 mg daily at the end of two weeks.  Slow titration avoids several problems such as low blood pressure, seizures, excessive sedation and an unnecessarily high dose.  Based upon response and adverse effects, the dosage should be increased every two to four weeks by 25 to 50 mg per day.  The maximum dose is 900 mg per day.  To avoid seizures, the dose should never be increased by more than 100 mg per day.  Clinical response may require three months to become evident, and is known to increase for at least two years in some patients.

Important Side Effects: Due to potentially dangerous side effects, clozapine should only be used in people with psychosis that does not respond to adequate trials of two or three other antipsychotics.  It is not uncommon for people taking clozapine to experience drowsiness or sedation, dizziness, headache, tremor, fainting, fast heartbeat, low blood pressure, excessive salivation, sweating, dry mouth and fever.

Agranulocytosis: The most dangerous potential side effect of clozapine is agranulocytosis, a potentially life-threatening blood disorder in which the white blood cells, needed to fight infections, are decreased.  Agranulocytosis occurs in approximately 1.3 percent of people who take clozapine every year.  Most often this happens between six and 12 weeks after starting clozapine, but agranulocytosis has appeared after two years.  For this reason , anyone taking clozapine needs to have a blood test weekly for the first six months of treatment, and then every other week indefinitely.  If an abnormal blood event is detected, weekly blood tests will be needed for an additional six months.  Only a one- or two-week supply of medication will be provided, enough to last until the next blood text.  If a patient has had agranulocytosis or another blood disorder while on clozapine, they must stop clozapine and not restart is.  Blood tests will be needed for four weeks after the last dose of clozapine is taken.

Seizures: Seizures have also been associated with clozapine, especially at higher doses; clozapine should be used with caution in patients with a history of seizure.

Myocarditis: Clozapine may also be associated with myocarditis (inflammation of the muscle walls of the heart) and should be discontinued immediately if myocarditis is suspected.  Other cardiovascular and respiratory effects, including orthostatic hypotension, have been found in patients.  The most serious cardiovascular and respiratory effects have been in patients also taking benzodiazepines or other psychotropic drugs.  Caution should be taken when administering clozapine with benzodiazepines or other psychotropic drugs.

Other: Some of the other possible side effects of clozapine include abdominal discomfort or heartburn; akathisia (internal sense of the need to move); blurred near vision; chest pain; chills; confusion; constipation; decreased sexual ability; difficulty breathing; difficulty urinating; high blood pressure; increase blood sugar; increased sweating; increased watering mouth or drooling; insomnia; liver problems (dark urine, decreased appetite, nausea, vomiting, yellow eyes, or skin); loss of bladder control; mental depression; nausea or vomiting; low blood pressure when standing up quickly; sore throat; sores, ulcers or white spots on lips or in mouth; swelling or pain in leg; trembling or shaking; unusual anxiety, nervousness, or irritability; unusual bleeding or bruising; unusual tiredness or weakness; unusually pale skin; weight gain.  As with any dopamine blocking agent, there is a risk of tardive dyskinesia, the development of abnormal movements that may not go away when the medication is discontinued, but this risk is smaller with clozapine than with other typical antipsychotic drugs.

This is not a complete list of all known or potential adverse effects.  Notify your prescriber or pharmacist of any symptoms that have started since you began taking this medication, changing its dose, or adding or changing other medication or diet.  Take care when performing any tasks (for example, driving or operating machinery) that requires your attention until you have experience with this drug and are confident you can perform the tasks safely.

Interactions with Other Medications: Clozapine should not be taken with other drugs that can cause low white blood cell counts, such as carbamazepine (Tegretol).  Because it has primary effects on the central nervous system (CNS), clozapine should be taken carefully with other psychotropic medications.  Taking warfarin (Coumadin) or digoxin (Lanoxin) with clozapine may cause an increase in blood concentrations of those drugs.  Cimetidine (Tagamet), erythromycin (E-Mycin) and fluvoxamine (Lubox) may increase blood levels of clozapine.  Clozapine may interact with anticholinergics, bone marrow depressants, fluvoxamine, hypotension-producing medications, and lithium.

This is not a complete list of all known or potential drug interactions.  To help prevent problems, always make sure that your pharmacist and all prescribers know about all medications you are taking, including over-the-counter drugs; dietary herbal supplements; folk or home remedies; or unusual foods, drinks, or dietary habits.

Identification: Clozapine is available as Clozaril in 25- and 100-mg pale-yellow tablets.  Clozapine is also available in a variety of generic formulations.

Storage: Store this medication at normal room temperature (59° F to 86° F) in a tightly closed, light- and moisture-resistant container.  If you have difficulty opening child-resistant containers, your pharmacist can provide a container that is easier to open.  Keep the medication out of direct sunlight and avoid storing it in a warm or humid area - such as the bathroom or kitchen - to prevent deterioration.  To prevent accidental poisoning, keep all mediations out of the reach of children.  Do not take an expired medication.  Do not transfer medication from one container to another.  Carefully discard discontinued medication where children cannot find it.

Edited by Lawrence H. Price, M.D.

ASERVICE OF…. The Brown University Psychopharmacology Update
Note: These guidelines are for general information only.For more specific information, consult your physician orpharmacist.

 

Home  | ADHD  | Anxiety  |  Depression  |  Medication Reference  |  Dr. Gruen Bio  |  Contact Dr. Gruen   Services  |  Legal Disclaimer 

This site provides useful general references for the generalpublic. It is not intended as a substitute for individualizedprofessional evaluation or treatment.

Copyright (c) 2001 TalkingDoc.com